TuesdaySep 11, 2012 1:47 pm

Bacterin International Holdings, Inc. (BONE) Reports Positive First Clinical Results for OsteoSponge SC Product

Bacterin International Holdings develops, manufactures, and markets biologics products, such as bone graft material and antimicrobial coatings, worldwide. The company's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair, and dermal growth. These products are used in a wide variety of surgeries. The company announced today that the first clinical results using the OsteoSponge SC product for regeneration of subchondral bone in complex lesions of the talus involving advanced subchondral bone damage have been published in the peer-reviewed journal, Foot & Ankle Specialist. The article reported on six…

Continue Reading

TuesdaySep 11, 2012 9:50 am

eMagin Corp. (EMAN) Increases Production Capacity Through Automation

eMagin has achieved automation of its newest SNU OLED deposition machine, increasing capacity and improving its ability to manufacture OLED microdisplays. Testing of the displays produced by the new automated system will be completed in mid-September; after which, the displays will be ready for shipping. eMagin is focused on producing OLED microdisplays, and is proficient in OLED microdisplay tech and mobile display systems. The company produces microdisplays equipped with magnification systems that allow portable, low-powered devices to achieve display imagery comparable to larger screen computers and televisions. eMagin produces displays for use in military, industrial, medical, and consumer markets. eMagin's…

Continue Reading

TuesdaySep 11, 2012 8:20 am

KSW, Inc. (KSW) and Related Companies Enter Merger Agreement

Yesterday, KSW, a leading HVAC provider, and Related Companies, a prominent diversified real estate firm, announced that they have entered into a definitive merger agreement. According to the agreement, a subsidiary of Related Companies (“Merger Sub”), will acquire all of the outstanding shares of common stock of KSW for $5.00 per share through a cash tender offer followed by a merger. Valued at approximately $32.1 million, KSW’s Board of Directors unanimously approved of the agreement. Under the terms of the merger agreement, Merger Sub will commence a tender offer for all of the outstanding shares of KSW before September 21,…

Continue Reading

MondaySep 10, 2012 5:11 pm

Compugen Ltd. (CGEN) Shows Promise in Fighting Autoimmune Disease

Autoimmunity is defined as an organ’s failure to recognize itself that leads to an immune response against the organ’s cells and tissues. In essence, it’s when a disease causes the body to attack itself. “Regulatory” cells, human cells that control the immune response, called “iTregs,” fail to work properly, and the body’s immune response attacks the body itself as well as the disease. Compugen Ltd., founded in 1993 and headquartered in Tel Aviv Israel, is a company focused on the development of drugs and other products for use against cancer and to assist with problems in the human body’s immune…

Continue Reading

MondaySep 10, 2012 3:23 pm

Bio-AMD, Inc. (BIAD) Issues Update on Hopeful Licensing for Commercialization-Ready Technologies

Bio-AMD is a development-stage company operating through its majority-owned UK subsidiaries: WDX Organisation Ltd., a global currency data reference company; and Bio AMD Ltd., a technology developer for medical diagnostic devices. In an update earlier today, BIAD announced that it is in informal discussions with potential partners regarding the commercialization of Bio AMD Ltd.’s hand-held Digital Strip Reader (DSR) and blood coagulation monitor (COAG) technologies. BIAD has readied both DSR and COAG for commercial development in conjunction with a partner, and this morning said that it is in “high level informal talks with suitable prospective partners for both these technologies.”…

Continue Reading

MondaySep 10, 2012 1:57 pm

BioLineRX Ltd. (BLRX) Reveals Preclinical Results Demonstrating Safety of Oral Treatment for Celiac Disease

BioLineRx is a biopharmaceutical development company building a portfolio of products for either unmet medical needs or to replace currently available therapies with significant advantages. The company currently has six clinical stage candidates along with nine products in various preclinical development stages for a number of indications. The company announced today that its orally available treatment for celiac disease, BL-7010, was found to be safe and well-tolerated and did not cause any adverse effects (even at high doses) in preclinical studies conducted to date. Additional studies showed that BL-7010 is specific to gliadins, the immunogenic peptides present in gluten that…

Continue Reading

MondaySep 10, 2012 1:31 pm

Chimera Energy Corp. (CHMR) Takes in PEMEX Data, Readies for Non-Hydraulic Extraction Roll Out at Mexico’s Largest Hydrocarbon Basin

Chimera Energy reported today that the massive Mexican state-owned Petroleos Mexicanos (PEMEX), the second largest (by market value) non-publicly listed company on earth, recently turned in the well data and logging reports in Poza Rica in order to aide deployment of the company's revolutionary exothermic non-hydraulic extraction method (zero water fracking). Given the undisputed leadership of PEMEX in Latin America's hydrocarbon sector and the rich, sizeable shale oil concentrations throughout the region, this tight-knit relationship with CHMR (as per last month's Memorandum of understanding between CHMR and PEMEX) puts the company in a prime position to roll out their revolutionary…

Continue Reading

MondaySep 10, 2012 1:16 pm

Senesco Technologies, Inc. (SNT) Reports Combining SNS01-T with Bortezomib Substantially Increases Effectiveness in Model of Multiple Myeloma

Senesco Technologies announced that the combination of bortezomib – the active component of VELCADE marketed by Millenium: The Takeda Oncology Company – and SNS01-T, which is the subject of Senesco’s ongoing multiple myeloma clinical study, results in substantially better performance in mouse xenograft models than either treatment by itself. SNS01-T enhances bortezomib’s ability to inhibit tumor growth in the mouse model and could potentially be a means of lowering the dose and reducing the severity of treatment-related side effects of bortezomib. As treatment increasingly involves combination therapy, it is important for SNS01-T to work well when added to current multiple…

Continue Reading

MondaySep 10, 2012 11:25 am

Teletouch Communications, Inc. (TLLE) Holds Shareholder Conference Call Covering 4th Quarter and Year End Financial Results and Operations

Teletouch Communications, Texas-based cellular services provider and growing consumer electronics distributor, recently held a shareholder conference call highlighting previously released financial results for the 4th fiscal quarter and fiscal year ending June 7, 2012, along with a number of operational issues. The call included Robert McMurrey (Chairman and CEO of Teletouch), Thomas “Kip” Hyde, Jr. (President & COO, and CEO of primary operating company PCI Hawk Electronics), Douglas Sloan (CFO), and Mike Dickens (Sr. VP of Operations). The core of the presentation dealt with the company’s move back to profitability and growth, coming out of a particularly challenging year involving…

Continue Reading

MondaySep 10, 2012 9:59 am

StrongBox From Crossroads Systems, Inc. (CRDS) Receives Prestigious HPA Engineering Excellence Award for 2012

Crossroads Systems, a provider of data protection and storage solutions worldwide, announced that its StrongBox® LTFS NAS archive solution has received the 2012 HPA Engineering Excellence Award. The prestigious award is a marquee portion of the HPA Awards, which have gradually become the standard against which creative and technical excellence in the art, science, and quality of post production is measured. The winners are chosen from a sizeable field of various technology offerings, including some of the most prominent companies in the industry. StrongBox is an enterprise-level offering that allows tape storage to perform exactly like disk-based storage by leveraging…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered